
N-Acetyl Epitalon Amidate Anti-aging CAS:307297-39-8
N-Acetyl Epitalon Amidate represents a cutting-edge advancement in peptide therapeutics, specifically engineered to combat aging at the molecular level. Derived from Epitalon, a synthetic tetrapeptide known for its telomerase-activating properties, this modified variant incorporates acetyl and amidate functional groups.
Introduction
N-Acetyl Epitalon Amidate represents a cutting-edge advancement in peptide therapeutics, specifically engineered to combat aging at the molecular level. Derived from Epitalon, a synthetic tetrapeptide known for its telomerase-activating properties, this modified variant incorporates acetyl and amidate functional groups. These structural enhancements aim to optimize stability, bioavailability, and efficacy, positioning it as a novel contender in longevity science. Unlike its predecessor, N-Acetyl Epitalon Amidate is designed to resist enzymatic degradation and enhance cellular uptake, offering a more potent and sustained anti-aging effect.

Features
1.Chemical Stability: The addition of acetyl and amidate groups shields the peptide from rapid breakdown by proteolytic enzymes, extending its active lifespan in the bloodstream.
2.Enhanced Bioavailability: Improved lipid solubility allows for efficient traversal across cell membranes, ensuring higher concentrations reach intracellular targets.
3.Mechanistic Depth:
○Telomerase Activation: Stimulates telomerase, an enzyme that elongates telomeres-protective caps on chromosomes that shorten with age. Slowing telomere attrition delays cellular senescence.
○Antioxidant Properties: Neutralizes reactive oxygen species (ROS), mitigating oxidative stress linked to aging and chronic diseases.
○Gene Regulation: Modulates expression of aging-related genes, such as p16 and p53, which govern cell cycle arrest and apoptosis.
4.Extended Half-Life: Structural modifications prolong systemic circulation, reducing dosing frequency compared to unmodified Epitalon.
Applications
●Cellular Rejuvenation: Promotes turnover of senescent cells, restoring tissue function in organs like the liver, skin, and brain.
●Dermatological Health: Enhances collagen synthesis and skin elasticity, reducing wrinkles and UV-induced damage.
●Neuroprotection: Supports cognitive function by reducing neuroinflammation and amyloid-beta accumulation, potentially delaying neurodegenerative disorders.
●Metabolic Optimization: Improves mitochondrial efficiency, aiding energy production and reducing fatigue associated with aging.
Benefits
●Extended Healthspan: Users report improved vitality, sharper cognition, and enhanced physical performance.
●Disease Mitigation: Preliminary models suggest utility in age-related conditions (e.g., osteoarthritis, cardiovascular disease) by preserving tissue integrity.
●Non-Invasive Longevity: Offers a pharmaceutical alternative to invasive therapies, with minimal side effects reported in preclinical studies.
Dosage and Administration
●Typical Range: 5–10 mg daily, administered subcutaneously for optimal absorption. Oral formulations are under investigation but may require higher doses due to lower bioavailability.
●Personalization: Dosage adjustments based on age, metabolic health, and telomere status are recommended. Geriatric populations might benefit from lower initial doses (2–5 mg) to assess tolerance.
Cycle Protocol
●Duration: Cycles of 6–8 weeks, followed by 4–6 week pauses to prevent receptor desensitization.
●Combination Therapies: Synergistic effects observed when paired with NAD+ boosters (e.g., NMN) or senolytics. Monitoring biomarkers (e.g., telomere length, inflammatory markers) during cycles is advised.
Half-Life
Pharmacokinetics: The acetyl and amidate groups extend the half-life to approximately 36–48 hours, compared to Epitalon's 20–24 hours. This allows for alternate-day dosing, improving compliance.
PTC (Peptide Transduction Complex)
●Innovative Delivery: PTC refers to a proprietary technology enhancing cellular uptake via covalent attachment to cell-penetrating peptides (CPPs). This method bypasses traditional absorption barriers, potentially increasing efficacy by 40–60%.
●Clinical Relevance: Early trials using PTC-formulated N-Acetyl Epitalon Amidate show accelerated tissue repair in epithelial and neural cells, though long-term data are pending.
Safety and Considerations
●Side Effects: Rare, mild reactions include transient erythema at injection sites or headaches. No evidence of carcinogenicity in animal models.
●Contraindications: Avoid during pregnancy or active cancer due to telomerase's dual role in aging and oncogenesis.
Future Directions
Research is exploring topical formulations for dermatological use and intranasal delivery for neurological benefits. Combination with CRISPR-based gene editing to target telomere maintenance pathways represents a frontier in personalized anti-aging regimens.
Clinical Data
|
Trade names |
Epithalon,Epithalone,Ala-Glu-Asp-Gly,L-Alanyl-L-glutamyl-L-aspartyl-glycine,UNII-O65P17785G |
|
CAS |
307297-39-8 |
|
Molar mass |
390.349 |
|
Formula |
C14H22N4O9 |
|
Purity |
Above 98% |
|
Apprarance |
5mg/vial, 10vials/box |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885

Conclusion
N-Acetyl Epitalon Amidate epitomizes the fusion of biotechnology and longevity science. Its multifaceted approach-addressing telomere dynamics, oxidative stress, and gene regulation-positions it as a transformative tool in aging intervention. While promising, rigorous clinical trials are essential to validate its safety and efficacy. Collaborating with healthcare providers to tailor use ensures alignment with individual health goals, heralding a new era in preventive medicine.
Hot Tags: n-acetyl epitalon amidate anti-aging cas:307297-39-8, China n-acetyl epitalon amidate anti-aging cas:307297-39-8 manufacturers, suppliers, factory
